Federman & Sherwood Investigates Community Clinic of Maui, Inc., dba Malama I Ke Ola Health Center (“Malama”) for Data Breach
Federman & Sherwood Investigates Community Clinic of Maui, Inc., dba Malama I Ke Ola Health Center (“Malama”) for Data Breach
Federman & Sherwood investigates Community Clinic of Maui, Inc., dba Malama I Ke Ola Health Center (“Malama”) for data breach. On May 7, 2024, Malama experienced a cybersecurity incident that impacted their network. Malama launched an investigation into the incident and determined that between May 4, 2024, and May 7, 2024, an unauthorized actor accessed and acquired certain individuals personal and sensitive information on their network. Malama provides comprehensive primary care medical, dental, health and prenatal services on the island of Maui.
The type of information potentially exposed includes:
- Full Name
- Social Security Number
- Other sensitive information
If you wish to discuss this action, obtain further information, and/or participate in this litigation, please contact Tashia Poore either by email at tdp@federmanlaw.com or visit our firm’s website www.federmanlaw.com.
Tashia Poore
FEDERMAN & SHERWOOD
(405) 235-1560
View source version on businesswire.com: https://www.businesswire.com/news/home/20240927144318/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks